Pfizer to run new ads over misleading ad complaints

Pfizer to run new ads over misleading ad complaints

Pfizer will pay $1 million to Oregon and run national advertising to correct prior ad campaigns that allegedly misrepresented products.

The new settlement, filed in Marion County Circuit Court, concerns ads for EpiPen, the company’s injectable form of epinephrine, and Zmax, an antiobiotic.

In May, the federal Food and Drug administration issued a warning letter saying an ad called “Max’s Birthday Party” had downplayed the "serious risks" of EpiPen. The ad was issued by a firm called Mylan Specialty, L.P. on behalf of Pfizer. The FDA called for corrective advertising.

Read more at OregonLive.com.

{biztweet}pfizer{/biztweet}